Holen Sie sich die Stockscreener-App
2.03
5.12%
-0.12
Schlusskurs vom Vortag:
$2.15
Offen:
$2.09
24-Stunden-Volumen:
42,769
Relative Volume:
0.29
Marktkapitalisierung:
$11.11M
Einnahmen:
$755.00K
Nettoeinkommen (Verlust:
$-9.33M
KGV:
-0.3555
EPS:
-5.71
Netto-Cashflow:
$-5.43M
1W Leistung:
-17.41%
1M Leistung:
-50.61%
6M Leistung:
-50.55%
1J Leistung:
-35.24%
1-Tages-Spanne:
$2.04
$2.2699
1-Wochen-Bereich:
$1.8001
$2.51
52-Wochen-Spanne:
$1.8001
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Vergleichen Sie MGRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.04 | 11.11M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
226.75 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.55 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.02 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.64 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 By Investing.com - Investing.com Australia
Mangoceuticals Inc (NASDAQ: MGRX) Stock: Bulls Should Watch This - Stocks Register
Mangoceuticals Expands into $33 Billion Addressable - GlobeNewswire
Mangoceuticals enters master distribution agreement for Diabetinol rights - TipRanks
Major Diabetes Market Breakthrough: Mangoceuticals Launches GLP-1 Alternative at Fraction of Cost - Stock Titan
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Announces Equity and Leadership Changes - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform - ACCESS Newswire
Shares of Healthcare Company Rise Following Product Availability Announcement - MSN
Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments - Nasdaq
Mangoceuticals Announces the Launch of “PeachesRx”a - GlobeNewswire
Mangoceuticals rises on launch of women's telehealth brand - TradingView
Mangoceuticals launches PeachesRx women’s telehealth brand - TipRanks
This New Women's Health Platform Could Disrupt the $48B GLP-1 Weight Loss Market - StockTitan
Mangoceuticals Inc. issues stock for consulting services By Investing.com - Investing.com South Africa
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals, Inc. Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology - Marketscreener.com
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - The Manila Times
Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK
Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan
Mangoceuticals executes exclusive distribution agreement with Propre - TipRanks
Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering - ACCESS Newswire
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market - ACCESS Newswire
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mangoceuticals Inc-Aktie (MGRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.20%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):